Recent progress in copolymer-mediated siRNA delivery

Journal of Drug Targeting

Volumn 20, Issue 7, 2012, Pages 551-560

  Wu, Zong Wei ^a   Chien, Chih Te ^a   Liu, Chia Yeh ^a   Yan, Jia Ying ^a   Lin, Shu Yi ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Copolymer; Endosomolysis; Polyplex; Vector

Indexed keywords

CHITOSAN; COPOLYMER; POLYAMIDOAMINE; POLYAMINE; POLYARGININE; POLYETHYLENEIMINE; POLYLYSINE; SMALL INTERFERING RNA;

CELL ORGANELLE; GENE DELIVERY SYSTEM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; ENDOSOMES; GENETIC VECTORS; POLYAMINES; POLYMERS; RNA, SMALL INTERFERING;

EID: 84863482675     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.699057     Document Type: Review

References (143)

1. Aagaard L, Rossi JJ. (2007). RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev, 59, 75-86.
2. Aigner A. (2008). Cellular delivery in vivo of siRNA-based therapeutics. Curr Pharm Des, 14, 3603-3619.
3. Aliabadi HM, Landry B, Bahadur RK, Neamnark A, Suwantong O, Uludag H. (2011). Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers. Macromol Biosci, 11, 662-672.
4. Alshamsan A, Hamdy S, Samuel J, El-Kadi AO, Lavasanifar A, Uludag H. (2010). The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Biomaterials, 31, 1420-1428.
5. Andersen Mø, Howard KA, Paludan SR, Besenbacher F, Kjems J. (2008). Delivery of siRNA from lyophilized polymeric surfaces. Biomaterials, 29, 506-512.
6. Arima H, Tsutsumi T, Yoshimatsu A, Ikeda H, Motoyama K, Higashi T, Hirayama F, Uekama K. (2011). Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/a-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression. Eur J Pharm Sci, 44, 375-384.
7. Auguste DT, Furman K, Wong A, Fuller J, Armes SP, Deming TJ, Langer R. (2008). Triggered release of siRNA from poly(ethylene glycol)- protected, pH-dependent liposomes. J Control Release, 130, 266-274.
8. Bartlett DW, Davis ME. (2007). Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjug Chem, 18, 456-468.
9. Benoit DS, Henry SM, Shubin AD, Hoffman AS, Stayton PS. (2010). pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1. Mol Pharm, 7, 442-455.
10. Benoit DS, Srinivasan S, Shubin AD, Stayton PS. (2011). Synthesis of folate-functionalized RAFT polymers for targeted siRNA delivery. Biomacromolecules, 12, 2708-2714.
11. Bolcato-Bellemin AL, Bonnet ME, Creusat G, Erbacher P, Behr JP. (2007). Sticky overhangs enhance siRNA-mediated gene silencing. Proc Natl Acad Sci USA, 104, 16050-16055.
12. Bouclier C, Moine L, Hillaireau H, Marsaud V, Connault E, Opolon P, Couvreur P, Fattal E, Renoir JM. (2008). Physicochemical characteristics and preliminary in vivo biological evaluation of nanocapsules loaded with siRNA targeting estrogen receptor α. Biomacromolecules, 9, 2881-2890.
13. Brissault B, Leborgne C, Scherman D, Guis C, Kichler A. (2011). Synthesis of poly(propylene glycol)-block-polyethylenimine triblock copolymers for the delivery of nucleic acids. Macromol Biosci, 11, 652-661.
14. Brunner T, Cohen S, Monsonego A. (2010). Silencing of proinflammatory genes targeted to peritoneal-residing macrophages using siRNA encapsulated in biodegradable microspheres. Biomaterials, 31, 2627-2636.
15. Bruno K. (2011). Using drug-excipient interactions for siRNA delivery. Adv Drug Deliv Rev, 63, 1210-1226.
16. Buyens K, Meyer M, Wagner E, Demeester J, De Smedt SC, Sanders NN. (2010). Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy. J Control Release, 141, 38-41.
17. Campolongo MJ, Luo D. (2009). Drug delivery: Old polymer learns new tracts. Nat Mater, 8, 447-448.
18. Canine BF, Wang Y, Ouyang W, Hatefi A. (2011). Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus. J Control Release, 151, 95-101.
19. Cao N, Cheng D, Zou S, Ai H, Gao J, Shuai X. (2011). The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials, 32, 2222-2232.
20. Chang Kang H, Bae YH. (2011). Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide. Biomaterials, 32, 4914-4924.
21. Cheng CJ, Saltzman WM. (2011). Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cellpenetrating peptides. Biomaterials, 32, 6194-6203.
22. Cho HY, Srinivasan A, Hong J, Hsu E, Liu S, Shrivats A, Kwak D, Bohaty AK, Paik HJ, Hollinger JO, Matyjaszewski K. (2011). Synthesis of biocompatible PEG-Based star polymers with cationic and degradable core for siRNA delivery. Biomacromolecules, 12, 3478-3486.
23. Cho YW, Kim JD, Park K. (2003). Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol, 55, 721-734.
24. Christie RJ, Miyata K, Matsumoto Y, Nomoto T, Menasco D, Lai TC, Pennisi M, Osada K, Fukushima S, Nishiyama N, Yamasaki Y, Kataoka K. (2011). Effect of polymer structure on micelles formed between siRNA and cationic block copolymer comprising thiols and amidines. Biomacromolecules, 12, 3174-3185.
25. Convertine AJ, Benoit DS, Duvall CL, Hoffman AS, Stayton PS. (2009). Development of a novel endosomolytic diblock copolymer for siRNA delivery. J Control Release, 133, 221-229.
26. Convertine AJ, Diab C, Prieve M, Paschal A, Hoffman AS, Johnson PH, Stayton PS. (2010). pH-responsive polymeric micelle carriers for siRNA drugs. Biomacromolecules, 11, 2904-2911.
27. Cun D, Foged C, Yang M, Frøkjaer S, Nielsen HM. (2010). Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm, 390, 70-75.
28. De Paula D, Bentley MV, Mahato RI. (2007). Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA, 13, 431-456.
29. de Wolf HK, Snel CJ, Verbaan FJ, Schiffelers RM, Hennink WE, Storm G. (2007). Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int J Pharm, 331, 167-175.
30. Duncan R. (2011). Polymer therapeutics as nanomedicines: new perspectives. Curr Opin Biotechnol, 22, 492-501.
31. El-Sayed ME, Hoffman AS, Stayton PS. (2005). Rational design of composition and activity correlations for pH-sensitive and glutathionereactive polymer therapeutics. J Control Release, 101, 47-58.
32. Fattal E, Bochot A. (2008). State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int J Pharm, 364, 237-248.
33. Fischer D, Bieber T, Li Y, Elsässer HP, Kissel T. (1999). A novel non-viralvector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res, 16, 1273-1279.
34. Gary DJ, Puri N, Won YY. (2007). Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release, 121, 64-73.
35. Ge Q, Eisen HN, Chen J. (2004). Use of siRNAs to prevent and treat influenza virus infection. Virus Res, 102, 37-42.
36. Heidel JD, Yu Z, Liu JY, Rele SM, Liang Y, Zeidan RK, Kornbrust DJ,Davis ME. (2007). Administration in non-human primates ofescalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci USA, 104, 5715-5721.
37. Hoffman AS, Stayton PS, Press O, Murthy N, Lackey CA, Cheung C, Black F, Campbell J, Fausto N, Kyriakides TR, Bornstein P. (2002). Design of 'smart' polymers that can direct intracellular drug delivery. Polym Adv Technol, 13, 992-999.
38. Hoon Jeong J, Christensen LV, Yockman JW, Zhong Z, Engbersen JF, Jong Kim W, Feijen J, Wan Kim S. (2007). Reducible poly(amidoethylenimine) directed to enhance RNA interference. Biomaterials, 28, 1912-1917.
39. Huang HY, Kuo WT, Chou MJ, Huang YY. (2011). Co-delivery of antivascularendothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. J Biomed Mater Res A, 97, 330-338.
40. Huh MS, Lee SY, Park S, Lee S, Chung H, Lee S, Choi Y, Oh YK, Park JH, Jeong SY, Choi K, Kim K, Kwon IC. (2010). Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J Control Release, 144, 134-143.
41. Ikeda Y, Suzuki R, Yoshitomi T, Nagasaki Y. (2011). Novel oligonucleotide carrier as scavenger for reactive oxygen species. Macromol Biosci, 11, 344-351.
42. Jackson AL, Linsley PS. (2010). Recognizing and avoiding siRNA offtarget effects for target identification and therapeutic application. Nat Rev Drug Discov, 9, 57-67.
43. Jensen DM, Cun D, Maltesen MJ, Frokjaer S, Nielsen HM, Foged C. (2010). Spray drying of siRNA-containing PLGA nanoparticlesintended for inhalation. J Control Release, 142, 138-145.
44. Jeong JH, Mok H, Oh YK, Park TG. (2009). siRNA conjugate delivery systems. Bioconjug Chem, 20, 5-14.
45. Jere D, Xu CX, Arote R, Yun CH, Cho MH, Cho CS. (2008). Poly(β-amino ester) as a carrier for si/shRNA delivery in lung cancer cells. Biomaterials, 29, 2535-2547.
46. Jere D, Jiang HL, Kim YK, Arote R, Choi YJ, Yun CH, Cho MH, Cho CS. (2009a). Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells. Int J Pharm, 378, 194-200.
47. Jere D, Kim JE, Arote R, Jiang HL, Kim YK, Choi YJ, Yun CH, Cho MH,Cho CS. (2009b). Akt1 silencing efficiencies in lung cancer cells by sh/si/ssiRNA transfection using a reductable polyspermine carrier. Biomaterials, 30, 1635-1647.
48. Kaneshiro TL, Lu ZR. (2009). Targeted intracellular codeliveryof chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials, 30, 5660-5666.
49. Katas H, Cevher E, Alpar HO. (2009). Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Int J Pharm, 369, 144-154.
50. Khan A, Benboubetra M, Sayyed PZ, Ng KW, Fox S, Beck G, Benter IF,Akhtar S. (2004). Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J Drug Target, 12, 393-404.
51. Kichler A, Leborgne C, Coeytaux E, Danos O. (2001). Polyethyleniminemediated gene delivery: a mechanistic study. J Gene Med, 3, 135-144.
52. Kim SH, Jeong JH, Ou M, Yockman JW, Kim SW, Bull DA. (2008). Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)- Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis. Biomaterials, 29,4439-4446.
53. Kim Y, Tewari M, Pajerowski JD, Cai S, Sen S, Williams JH, Williams J, Sirsi SR, Sirsi S, Lutz GJ, Lutz G, Discher DE. (2009). Polymersome delivery of siRNA and antisense oligonucleotides. J Control Release, 134, 132-140.
54. Kim C, Lee Y, Kim JS, Jeong JH, Park TG. (2010a). Thermally triggered cellular uptake of quantum dots immobilized with poly(Nisopropylacrylamide)and cell penetrating peptide. Langmuir, 26, 14965-14969.
55. Kim HJ, Ishii A, Miyata K, Lee Y, Wu S, Oba M, Nishiyama N, Kataoka K. (2010b). Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomalescaping function for enhanced siRNA-mediated gene knockdown. J Control Release, 145, 141-148.
56. Kim SH, Ou M, Bull DA, Kim SW. (2010c). Reductive degradation behavior of bioreducible poly(disulfide amine) for enhancing SiRNA efficiency. Macromol Biosci, 10, 898-905.
57. Kim SW, Kim NY, Choi YB, Park SH, Yang JM, Shin S. (2010d). RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system. J Control Release, 143, 335-343.
58. Kim C, Shah BP, Subramaniam P, Lee KB. (2011). Synergistic induction of apoptosis in brain cancer cells by targeted codelivery of siRNA and anticancer drugs. Mol Pharm, 8, 1955-1961.
59. Kissel TH, Nguyen J, Reul R, Roesler S, Dayyoub E, Schmehl T, GesslerT, Seeger W. (2010). Amine-modified poly(Vinyl Alcohol)s as nonviral vectors for siRNA delivery: Effects of the degree of amine substitution on physicochemical properties and knockdown efficiency. Pharm Res, 27, 2670-2682.
60. Kong WH, Sung DK, Shim YH, Bae KH, Dubois P, Park TG, Kim JH, Seo SW. (2009). Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post- PEGylation. J Control Release, 138, 141-147.
61. Kriegel C, Amiji M. (2011). Oral TNF-a gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease. J Control Release 150 77-86.
62. Lee JH, Cha KE, Kim MS, Hong HW, Chung DJ, Ryu G, Myung H. (2009). Nanosized polyamidoamine (PAMAM) dendrimer-induced apoptosis mediated by mitochondrial dysfunction. Toxicol Lett,190, 202-207.
63. Lee SH, Choi SH, Kim SH, Park TG. (2008). Thermally sensitive cationicpolymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J Control Release, 125, 25-32.
64. Lee SY, Huh MS, Lee S, Lee SJ, Chung H, Park JH, Oh YK, Choi K, Kim K, Kwon IC. (2010a). Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes forefficient gene silencing. J Control Release, 141, 339-346.
65. Lee YK, Kim KS, Kim JS, Baek JE, Park SI, Jeong HY, Yoon SS, Jung KC,Song HG, Park YS. (2010b). Leukemia-specific siRNA delivery by immunonanoplexes consisting of anti-JL1 minibody conjugated tooligo-9 Arg-peptides. Mol Cells, 29, 457-462.
66. Leng Q, Scaria P, Zhu J, Ambulos N, Campbell P, Mixson AJ. (2005).Highly branched HK peptides are effective carriers of siRNA. J Gene Med, 7, 977-986.
67. Lin D, Huang Y, Jiang Q, Zhang W, Yue X, Guo S, Xiao P, Du Q, Xing J, Deng L, Liang Z, Dong A. (2011). Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery.Biomaterials, 32, 8730-8742.
68. Lin YL, Jiang G, Birrell LK, El-Sayed ME. (2010). Degradable,pH- sensitive, membrane-destabilizing, comb-like polymers forintracellular delivery of nucleic acids. Biomaterials, 31, 7150-7166.
69. Liu C, Zhao G, Liu J, Ma N, Chivukula P, Perelman L, Okada K, Chen Z,Gough D, Yu L. (2009). Novel biodegradable lipid nano complexfor siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel. J Control Release, 140, 277-283.
70. Liu Q, Paroo Z. (2010). Biochemical principles of small RNA pathways.Annu Rev Biochem, 79, 295-319.
71. Liu X, Howard KA, Dong M, Andersen Mø, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J. (2007). The influence of polymeric properties on chitosan/siRNA nanoparticle formulationand gene silencing. Biomaterials, 28, 1280-1288.
72. Liu Y, Samsonova O, Sproat B, Merkel O, Kissel T. (2011). Biophysical characterization of hyper-branched polyethylenimine-graftpolycaprolactone-block- mono-methoxyl-poly(ethylene glycol) copolymers (hy-PEI-PCL-mPEG) for siRNA delivery. J ControlRelease, 153, 262-268.
73. Manaka T, Suzuki A, Takayama K, Imai Y, Nakamura H, Takaoka K. (2011). Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation.Biomaterials, 32, 9642-9648.
74. Mao CQ, Du JZ, Sun TM, Yao YD, Zhang PZ, Song EW, Wang J. (2011). A biodegradable amphiphilic and cationic triblock copolymer for he delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials, 32, 3124-3133.
75. Martin SE, Caplen NJ. (2007). Applications of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet, 8, 81-108.
76. Matsumoto S, Christie RJ, Nishiyama N, Miyata K, Ishii A, Oba M, Koyama H, Yamasaki Y, Kataoka K. (2009). Environment-responsive block copolymer micelles with a disulfide cross-linked core forenhanced siRNA delivery. Biomacromolecules, 10, 119-127.
77. Merdan T, Kopecek J, Kissel T. (2002). Prospects for cationic polymers ingene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev, 54, 715-758.
78. Merkel OM, Beyerle A, Beckmann BM, Zheng M, Hartmann RK, Stöger T, Kissel TH. (2011). Polymer-related off-target effects in non-viralsiRNA delivery. Biomaterials, 32, 2388-2398.
79. Merkel OM, Librizzi D, Pfestroff A, Schurrat T, Buyens K, Sanders NN, De Smedt SC, Béhé M, Kissel T. (2009). Stability of siRNApolyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single PhotonEmission Computed Tomography (SPECT) imaging. J Control Release, 138, 148-159.
80. Meyer M, Dohmen C, Philipp A, Kiener D, Maiwald G, Scheu C, Ogris M, Wagner E. (2009). Synthesis and biological evaluation of Synthesis and biological evaluation of bioresponsive and endosomolytic siRNA-polymer conjugate bioresponsive and endosomolytic siRNA-polymer conjugate. MolPharm 6 752-762.
81. Meyer M, Philipp A, Oskuee R, Schmidt C, Wagner E. (2008). Breathinglife into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J Am Chem Soc, 130, 3272-3273.
82. Mintzer MA, Simanek EE. (2009). Nonviral vectors for gene delivery. Chem Rev, 109, 259-302.
83. Mittnacht U, Hartmann H, Hein S, Oliveira H, Dong M, P'go AP, Kjems J, Howard KA, Schlosshauer B. (2010). Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neuriteoutgrowth. Nano Lett, 10, 3933-3939.
84. Montazeri Aliabadi H, Landry B, Mahdipoor P, Uludag H. (2011).Induction of apoptosis by survivin silencing through siRNA deliveryin a human breast cancer cell line. Mol Pharm, 8, 1821-1830.
85. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. (2008). Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials, 29, 3477-3496.
86. Nam HY, McGinn A, Kim PH, Kim SW, Bull DA. (2010). Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials, 31, 8081-8087.
87. Nguyen J, Steele TW, Merkel O, Reul R, Kissel T. (2008). Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy. J Control Release, 132, 243-251.
88. Noh SM, Park MO, Shim G, Han SE, Lee HY, Huh JH, Kim MS, Choi JJ, Kim K, Kwon IC, Kim JS, Baek KH, Oh YK. (2010). Pegylated polyl- arginine derivatives of chitosan for effective delivery of siRNA. J Control Release, 145, 159-164.
89. Oh YK, Park TG. (2009). siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev, 61, 850-862.
90. Park K, Lee MY, Kim KS, Hahn SK. (2010). Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneiminehyaluronic acid conjugate. Biomaterials, 31, 5258-5265.
91. Patil ML, Zhang M, Minko T. (2011). Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing. ACS Nano, 5, 1877-1887.
92. Pavan GM, Posocco P, Tagliabue A, Maly M, Malek A, Danani A, Ragg E, Catapano CV, Pricl S. (2010). PAMAM dendrimers for siRNA delivery: computational and experimental insights. Chemistry, 16, 7781-7795.
93. Philipp A, Meyer M, Zintchenko A, Wagner E. (2011). Functional modification of amide-crosslinked oligoethylenimine forimproved siRNA delivery. React Funct Polym, 71, 288-293.
94. Ping Y, Liu C, Zhang Z, Liu KL, Chen J, Li J. (2011). Chitosan-graft-(PEI- β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Biomaterials, 32, 8328-8341.
95. Pittella F, Zhang M, Lee Y, Kim HJ, Tockary T, Osada K, Ishii T, Miyata K, Nishiyama N, Kataoka K. (2011). Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles fromcalcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity. Biomaterials, 32, 3106-3114.
96. Putnam D. (2006). Polymers for gene delivery across length scales. Nat Mater, 5, 439-451.
97. Rahbek UL, Nielsen AF, Dong M, You Y, Chauchereau A, Oupicky D, Besenbacher F, Kjems J, Howard KA. (2010). Bioresponsive hyperbranched polymers for siRNA and miRNA delivery. J Drug Target, 18, 812-820.
98. Remaut K, Symens N, Lucas B, Demeester J, De Smedt SC. (2010). Efficient delivery of intact phosphodiester oligonucleotides by poly-β-amino esters. J Control Release, 144, 65-74.
99. Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL,Bertin SL, Reppen TW, Chu Q, Blokhin AV, Hagstrom JE, Wolff JA. (2007). Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA, 104, 12982-12987.
100. San Juan A, Bala M, Hlawaty H, Portes P, Vranckx R, Feldman LJ, Letourneur D. (2009). Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA. Biomacromolecules, 10, 3074-3080.
101. Schiffelers RM, van Rooy I, Storm G. (2005). siRNA-mediated inhibition of angiogenesis. Expert Opin Biol Ther, 5, 359-368.
102. Schlegel A, Largeau C, Bigey P, Bessodes M, Lebozec K, Scherman D, Escriou V. (2011). Anionic polymers for decreased toxicity andenhanced in vivo delivery of siRNA complexed with cationic liposomes. J Control Release, 152, 393-401.
103. Shen Y. (2008). Advances in the development of siRNA-based therapeutics for cancer. IDrugs, 11, 572-578.
104. Shi J, Xiao Z, Votruba AR, Vilos C, Farokhzad OC. (2011). Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. Angew Chem Int Ed Engl, 50, 7027-7031.
105. Shim MS, Kwon YJ. (2011). Dual mode polyspermine with tunable degradability for plasmid DNA and siRNA delivery. Biomaterials,32, 4009-4020.
106. Siegwart DJ, Whitehead KA, Nuhn L, Sahay G, Cheng H, Jiang S, Ma M, Lytton-Jean A, Vegas A, Fenton P, Levins CG, Love KT, Lee H, Cortez C, Collins SP, Li YF, Jang J, Querbes W, Zurenko C, Novobrantseva T, Langer R, Anderson DG. (2011). Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc Natl Acad Sci USA, 108, 12996-13001.
107. Singh A, Suri S, Roy K. (2009). In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells. Biomaterials, 30, 5187-5200.
108. Singh HD, Wang G, Uludag H, Unsworth LD. (2010). Poly-l-lysinecoated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics. Acta Biomater, 6, 4277-4284.
109. Smith AE, Sizovs A, Grandinetti G, Xue L, Reineke TM. (2011). Diblock glycopolymers promote colloidal stability of polyplexes and effective pDNA and siRNA delivery under physiological salt and serum conditions. Biomacromolecules, 12, 3015-3022.
110. Sparks SM, Waite CL, Harmon AM, Nusblat LM, Roth CM, Uhrich KE. (2011). Efficient intracellular siRNA delivery by ethyleneiminemodified amphiphilic macromolecules. Macromol Biosci, 11, 1192-1200.
111. Suh MS, Shim G, Lee HY, Han SE, Yu YH, Choi Y, Kim K, Kwon IC, WeonKY, Kim YB, Oh YK. (2009). Anionic amino acid-derived cationiclipid for siRNA delivery. J Control Release, 140, 268-276.
112. Sun HK, Ji HJ, Kim TI, Sung WK, Bull DA. (2009). VEGF siRNA deliverysystem using arginine-grafted bioreducible poly(disulfide amine). Mol Pharm, 6, 718-726.
113. Sun HK, Ji HJ, Kyung CC, Sung WK, Tae GP. (2005). Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J Control Release, 104, 223-232.
114. Sun TM, Du JZ, Yan LF, Mao HQ, Wang J. (2008). Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. Biomaterials, 29, 4348-4355.
115. Takemoto H, Ishii A, Miyata K, Nakanishi M, Oba M, Ishii T, Yamasaki Y, Nishiyama N, Kataoka K. (2010). Polyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery system. Biomaterials, 31, 8097-8105.
116. Tamura A, Oishi M, Nagasaki Y. (2009). Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure. Biomacromolecules, 10, 1818-1827.
117. Tamura A, Oishi M, Nagasaki Y. (2010). Efficient siRNA delivery based on PEGylated and partially quaternized polyamine nanogels: enhanced gene silencing activity by the cooperative effect of tertiary and quaternary amino groups in the core. J Control Release, 146, 378-387.
118. Tarcha PJ, Pelisek J, Merdan T, Waters J, Cheung K, von Gersdorff K, Culmsee C, Wagner E. (2007). Synthesis and characterization of chemically condensed oligoethylenimine containing β-aminopropionamide linkages for siRNA delivery. Biomaterials, 28, 3731-3740.
119. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. (1986). Dendritic macromolecules: Synthesis of strarbust dendrimers. Macromolecules, 19, 2466-2468.
120. Tsai LR, Chen MH, Chien CT, Chen MK, Lin FS, Lin KM, Hwu YK, Yang CS, Lin SY. (2011). A single-monomer derived linear-like PEI-co- PEG for siRNA delivery and silencing. Biomaterials, 32, 3647-3653.
121. Tsutsumi T, Hirayama F, Uekama K, Arima H. (2007). Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA). J Control Release, 119, 349-359.
122. Uekama K, Hirayama F, Irie T. (1998). Cyclodextrin Drug Carrier Systems. Chem Rev, 98, 2045-2076.
123. Vandenbroucke RE, De Geest BG, Bonn? S, Vinken M, Van Haecke T, Heimberg H, Wagner E, Rogiers V, De Smedt SC, Demeester J, Sanders NN. (2008). Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(β-amino esters). J Gene Med, 10, 783-794.
124. Varkouhi AK, Scholte M, Storm G, Haisma HJ. (2011). Endosomal escape pathways for delivery of biologicals. J Control Release, 151, 220-228.
125. Wang XL, Jensen R, Lu ZR. (2007). A novel environment- sensitivebiodegradable polydisulfide with protonatable pendants for nucleic acid delivery. J Control Release, 120, 250-258.
126. Wang XL, Nguyen T, Gillespie D, Jensen R, Lu ZR. (2008).A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery. Biomaterials, 29, 15-22.
127. Wang XL, Xu R, Lu ZR. (2009). A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption forefficient receptor-mediated siRNA delivery. J Control Release, 134, 207-213.
128. Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N. (2010). Orally delivered thioketal nanoparticles loaded with TNFa- siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater, 9, 923-928.
129. Winkler J. (2011). Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides. Ther Deliv, 2, 891-905.
130. Wolfert MA, Dash PR, Nazarova O, Oupicky D, Seymour LW, Smart S, Strohalm J, Ulbrich K. (1999). Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug Chem,10, 993-1004.
131. Wolff JA, Rozema DB. (2008). Breaking the bonds: non-viral vectors become chemically dynamic. Mol Ther, 16, 8-15.
132. Wong SC, Wakefield D, Klein J, Monahan SD, Rozema DB, Lewis DL, Higgs L, Ludtke J, Sokoloff AV, Wolff JA. (2006). Hepatocyte targeting of nucleic acid complexes and liposomes by a T7 phage p17 peptide. Mol Pharm, 3, 386-397.
133. Woodrow KA, Cu Y, Booth CJ, Saucier-Sawyer JK, Wood MJ, Saltzman WM. (2009). Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater, 8, 526-533.
134. Wu GY, Wu CH. (1987). Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem, 262, 4429-4432.
135. Xiong XB, Lavasanifar A. (2011). Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano, 5, 5202-5213.
136. Xiong XB, Uludag H, Lavasanifar A. (2009). Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials, 30, 242-253.
137. Xiong XB, Uludag H, Lavasanifar A. (2010). Virus-mimetic polymeric micelles for targeted siRNA delivery. Biomaterials, 31, 5886-5893.
138. Xu H, Meng F, Zhong Z. (2009). Reversibly crosslinked temperatureresponsive nano-sized polymersomes: Synthesis and triggered drug release. J Mater Chem, 19, 4183-4190.
139. York AW, Huang F, McCormick CL. (2010). Rational design of targeted cancer therapeutics through the multiconjugation of folate and cleavable siRNA to RAFT-synthesized (HPMA-s-APMA) copolymers. Biomacromolecules, 11, 505-514.
140. Zhang C, Tang N, Liu X, Liang W, Xu W, Torchilin VP. (2006). siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. J Control Release, 112,229-239.
141. Zhang J, Kissounko DA, Lee SE, Gellman SH, Stahl SS. (2009). Access to poly-β-peptides with functionalized side chains and end groups via controlled ring-opening polymerization of β-lactams. J Am Chem Soc, 131, 1589-1597.
142. Zhang S, Zhao B, Jiang H, Wang B, Ma B. (2007). Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release, 123, 1-10.
143. Zhou J, Wu J, Hafdi N, Behr JP, Erbacher P, Peng L. (2006). PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun (Camb), 2362-2364.